Return On Equity in % of Medpace Holdings, Inc. from Q2 2017 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Medpace Holdings, Inc. quarterly/annual Return On Equity history and change rate from Q2 2017 to Q3 2025.
  • Medpace Holdings, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 91.9 %, a 80.6% increase year-over-year.
  • Medpace Holdings, Inc. annual Return On Equity for 2024 was 51.5 %, a 19.5% decline from 2023.
  • Medpace Holdings, Inc. annual Return On Equity for 2023 was 64 %, a 5.89% increase from 2022.
  • Medpace Holdings, Inc. annual Return On Equity for 2022 was 60.4 %, a 196% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Medpace Holdings, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 91.9 +41 +80.6% 01 Jul 2025 30 Sep 2025
Q2 2025 67.7 +12.5 +22.7% 01 Apr 2025 30 Jun 2025
Q1 2025 54.4 -5.38 -9.01% 01 Jan 2025 31 Mar 2025
Q4 2024 51.5 -12.5 -19.5% 01 Oct 2024 31 Dec 2024
Q3 2024 50.9 -17.6 -25.7% 01 Jul 2024 30 Sep 2024
Q2 2024 55.1 -17.7 -24.3% 01 Apr 2024 30 Jun 2024
Q1 2024 59.7 -15.5 -20.6% 01 Jan 2024 31 Mar 2024
Q4 2023 64 +3.56 +5.89% 01 Oct 2023 31 Dec 2023
Q3 2023 68.5 +27.1 +65.4% 01 Jul 2023 30 Sep 2023
Q2 2023 72.9 +42.3 +138% 01 Apr 2023 30 Jun 2023
Q1 2023 75.2 +51 +211% 01 Jan 2023 31 Mar 2023
Q4 2022 60.4 +40 +196% 01 Oct 2022 31 Dec 2022
Q3 2022 41.4 +20 +93.4% 01 Jul 2022 30 Sep 2022
Q2 2022 30.6 +9.33 +44% 01 Apr 2022 30 Jun 2022
Q1 2022 24.2 +4.16 +20.8% 01 Jan 2022 31 Mar 2022
Q4 2021 20.4 +1.38 +7.25% 01 Oct 2021 31 Dec 2021
Q3 2021 21.4 +4.68 +28% 01 Jul 2021 30 Sep 2021
Q2 2021 21.2 +6.36 +42.8% 01 Apr 2021 30 Jun 2021
Q1 2021 20 +4.23 +26.8% 01 Jan 2021 31 Mar 2021
Q4 2020 19.1 +4.16 +27.9% 01 Oct 2020 31 Dec 2020
Q3 2020 16.7 +2.19 +15.1% 01 Jul 2020 30 Sep 2020
Q2 2020 14.9 +0.35 +2.41% 01 Apr 2020 30 Jun 2020
Q1 2020 15.8 +2.4 +17.9% 01 Jan 2020 31 Mar 2020
Q4 2019 14.9 +1.78 +13.6% 01 Oct 2019 31 Dec 2019
Q3 2019 14.5 +3.01 +26.1% 01 Jul 2019 30 Sep 2019
Q2 2019 14.5 +4.71 +48% 01 Apr 2019 30 Jun 2019
Q1 2019 13.4 +5.12 +62.1% 01 Jan 2019 31 Mar 2019
Q4 2018 13.1 +6.27 +91.7% 01 Oct 2018 31 Dec 2018
Q3 2018 11.5 +6.86 +147% 01 Jul 2018 30 Sep 2018
Q2 2018 9.81 +6.06 +161% 01 Apr 2018 30 Jun 2018
Q1 2018 8.25 01 Jan 2018 31 Mar 2018
Q4 2017 6.84 01 Oct 2017 31 Dec 2017
Q3 2017 4.66 01 Jul 2017 30 Sep 2017
Q2 2017 3.76 01 Apr 2017 30 Jun 2017

Medpace Holdings, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 51.5 -12.5 -19.5% 01 Jan 2024 31 Dec 2024
2023 64 +3.56 +5.89% 01 Jan 2023 31 Dec 2023
2022 60.4 +40 +196% 01 Jan 2022 31 Dec 2022
2021 20.4 +1.38 +7.25% 01 Jan 2021 31 Dec 2021
2020 19.1 +4.16 +27.9% 01 Jan 2020 31 Dec 2020
2019 14.9 +1.78 +13.6% 01 Jan 2019 31 Dec 2019
2018 13.1 +6.27 +91.7% 01 Jan 2018 31 Dec 2018
2017 6.84 01 Jan 2017 31 Dec 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.